Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 Dec;107(Suppl 6):853–858. doi: 10.1289/ehp.99107s6853

Why is environmental tobacco smoke more strongly associated with coronary heart disease than expected? A review of potential biases and experimental data.

G Howard 1, M J Thun 1
PMCID: PMC1566209  PMID: 10592142

Abstract

Despite exposure levels estimated to be equivalent to smoking only 0. 1-1.0 cigarettes per day, exposure to environmental tobacco smoke (ETS) is estimated to increase the risk of death from coronary heart disease (CHD) between 25 and 35% above the risk of nonexposed persons. This surprisingly large risk associated with a seemingly small exposure has raised doubts about the validity of attributing the increased CHD risk to ETS exposure. This paper reviews various biases that have been hypothesized to account for the increased CHD risk associated with ETS in the epidemiologic studies and characterizes the adverse effects of ETS on thrombosis, vascular endothelium, and exercise tolerance observed in experimental studies of humans and laboratory animals. None of the identified factors that has been proposed to introduce a spurious association between ETS and heart disease seem to invalidate the epidemiologic findings, either separately or in combination. In addition, experimental studies of ETS and heart disease demonstrate that acute exposure of humans and other species to ETS affects platelet function, vascular endothelium, and myocardial exercise tolerance at exposure concentrations widely prevalent in the workplace. Because exposure to ETS affects multiple physiologic pathways, it appears biologically plausible that ETS could cause the substantial increase in CHD risk that has been observed in epidemiologic studies.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronow W. S. Effect of passive smoking on angina pectoris. N Engl J Med. 1978 Jul 6;299(1):21–24. doi: 10.1056/NEJM197807062990105. [DOI] [PubMed] [Google Scholar]
  2. Aviado D. M. Cardiovascular disease and occupational exposure to environmental tobacco smoke. Am Ind Hyg Assoc J. 1996 Mar;57(3):285–294. doi: 10.1080/15428119691015025. [DOI] [PubMed] [Google Scholar]
  3. Bero L. A., Glantz S. A., Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA. 1994 Jul 13;272(2):133–136. [PubMed] [Google Scholar]
  4. Blache D., Bouthillier D., Davignon J. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis. 1992 Apr;93(3):179–188. doi: 10.1016/0021-9150(92)90254-e. [DOI] [PubMed] [Google Scholar]
  5. Burghuber O. C., Punzengruber C., Sinzinger H., Haber P., Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986 Jul;90(1):34–38. doi: 10.1378/chest.90.1.34. [DOI] [PubMed] [Google Scholar]
  6. Burghuber O. C., Punzengruber C., Sinzinger H., Haber P., Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986 Jul;90(1):34–38. doi: 10.1378/chest.90.1.34. [DOI] [PubMed] [Google Scholar]
  7. Celermajer D. S., Adams M. R., Clarkson P., Robinson J., McCredie R., Donald A., Deanfield J. E. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996 Jan 18;334(3):150–154. doi: 10.1056/NEJM199601183340303. [DOI] [PubMed] [Google Scholar]
  8. Coultas D. B., Howard C. A., Peake G. T., Skipper B. J., Samet J. M. Discrepancies between self-reported and validated cigarette smoking in a community survey of New Mexico Hispanics. Am Rev Respir Dis. 1988 Apr;137(4):810–814. doi: 10.1164/ajrccm/137.4.810. [DOI] [PubMed] [Google Scholar]
  9. Davis J. W., Davis R. F., Hassanein K. M. In healthy habitual smokers acetylsalicylic acid abolishes the effects of tobacco smoke on the platelet aggregate ratio. Can Med Assoc J. 1982 Mar 15;126(6):637–639. [PMC free article] [PubMed] [Google Scholar]
  10. Davis J. W., Davis R. F. Prevention of cigarette smoking-induced platelet aggregate formation by aspirin. Arch Intern Med. 1981 Feb;141(2):206–207. [PubMed] [Google Scholar]
  11. Davis J. W., Hartman C. R., Lewis H. D., Jr, Shelton L., Eigenberg D. A., Hassanein K. M., Hignite C. E., Ruttinger H. A. Cigarette smoking--induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med. 1985 Apr;105(4):479–483. [PubMed] [Google Scholar]
  12. Davis J. W., Shelton L., Eigenberg D. A., Hignite C. E., Watanabe I. S. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther. 1985 May;37(5):529–533. doi: 10.1038/clpt.1985.83. [DOI] [PubMed] [Google Scholar]
  13. Davis J. W., Shelton L., Hartman C. R., Eigenberg D. A., Ruttinger H. A. Smoking-induced changes in endothelium and platelets are not affected by hydroxyethylrutosides. Br J Exp Pathol. 1986 Oct;67(5):765–771. [PMC free article] [PubMed] [Google Scholar]
  14. Davis J. W., Shelton L., Watanabe I. S., Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med. 1989 Feb;149(2):386–389. [PubMed] [Google Scholar]
  15. FitzGerald G. A., Oates J. A., Nowak J. Cigarette smoking and hemostatic function. Am Heart J. 1988 Jan;115(1 Pt 2):267–271. doi: 10.1016/0002-8703(88)90648-5. [DOI] [PubMed] [Google Scholar]
  16. Glantz S. A., Parmley W. W. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation. 1991 Jan;83(1):1–12. doi: 10.1161/01.cir.83.1.1. [DOI] [PubMed] [Google Scholar]
  17. Glantz S. A., Parmley W. W. Passive smoking and heart disease. Mechanisms and risk. JAMA. 1995 Apr 5;273(13):1047–1053. [PubMed] [Google Scholar]
  18. Joseph P. M., Witten M. L., Burke C. H., Hales C. A. The effects of chronic sidestream cigarette smoke exposure on eicosanoid production by tracheal epithelium. Exp Lung Res. 1996 May-Jun;22(3):317–335. doi: 10.3109/01902149609031778. [DOI] [PubMed] [Google Scholar]
  19. Kawachi I., Colditz G. A., Speizer F. E., Manson J. E., Stampfer M. J., Willett W. C., Hennekens C. H. A prospective study of passive smoking and coronary heart disease. Circulation. 1997 May 20;95(10):2374–2379. doi: 10.1161/01.cir.95.10.2374. [DOI] [PubMed] [Google Scholar]
  20. Kritz H., Sinzinger H. Passive smoking, platelet function and atherosclerosis. Wien Klin Wochenschr. 1996;108(18):582–588. [PubMed] [Google Scholar]
  21. Law M. R., Morris J. K., Wald N. J. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997 Oct 18;315(7114):973–980. doi: 10.1136/bmj.315.7114.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LeVois M. E., Layard M. W. Publication bias in the environmental tobacco smoke/coronary heart disease epidemiologic literature. Regul Toxicol Pharmacol. 1995 Feb;21(1):184–191. doi: 10.1006/rtph.1995.1023. [DOI] [PubMed] [Google Scholar]
  23. Lee P. N. Lung cancer and passive smoking: association of an artefact due to misclassification of smoking habits? Toxicol Lett. 1987 Jan;35(1):157–162. doi: 10.1016/0378-4274(87)90102-0. [DOI] [PubMed] [Google Scholar]
  24. Leone A., Mori L., Bertanelli F., Fabiano P., Filippelli M. Indoor passive smoking: its effect on cardiac performance. Int J Cardiol. 1991 Nov;33(2):247–251. doi: 10.1016/0167-5273(91)90354-r. [DOI] [PubMed] [Google Scholar]
  25. Mantel N. Dubious evidence of heart and cancer deaths due to passive smoking. J Clin Epidemiol. 1992 Aug;45(8):809–813. doi: 10.1016/0895-4356(92)90062-r. [DOI] [PubMed] [Google Scholar]
  26. McMurray R. G., Hicks L. L., Thompson D. L. The effects of passive inhalation of cigarette smoke on exercise performance. Eur J Appl Physiol Occup Physiol. 1985;54(2):196–200. doi: 10.1007/BF02335929. [DOI] [PubMed] [Google Scholar]
  27. Nowak J., Andersson K., Benthin G., Chen J., Karlberg K. E., Sylvén C. Effect of nicotine infusion in humans on platelet aggregation and urinary excretion of a major thromboxane metabolite. Acta Physiol Scand. 1996 May;157(1):101–107. doi: 10.1046/j.1365-201X.1996.474216000.x. [DOI] [PubMed] [Google Scholar]
  28. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994 May 5;330(18):1287–1294. doi: 10.1056/NEJM199405053301808. [DOI] [PubMed] [Google Scholar]
  29. Penn A., Chen L. C., Snyder C. A. Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation. 1994 Sep;90(3):1363–1367. doi: 10.1161/01.cir.90.3.1363. [DOI] [PubMed] [Google Scholar]
  30. Penn A., Keller K., Snyder C., Nadas A., Chen L. C. The tar fraction of cigarette smoke does not promote arteriosclerotic plaque development. Environ Health Perspect. 1996 Oct;104(10):1108–1113. doi: 10.1289/ehp.961041108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Penn A., Snyder C. A. 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation. 1996 Feb 1;93(3):552–557. doi: 10.1161/01.cir.93.3.552. [DOI] [PubMed] [Google Scholar]
  32. Penn A., Snyder C. A. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 1993 Oct;88(4 Pt 1):1820–1825. doi: 10.1161/01.cir.88.4.1820. [DOI] [PubMed] [Google Scholar]
  33. Pittilo R. M., Mackie I. J., Rowles P. M., Machin S. J., Woolf N. Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin. Thromb Haemost. 1982 Oct 29;48(2):173–176. [PubMed] [Google Scholar]
  34. Roberts K. A., Rezai A. A., Pinkerton K. E., Rutledge J. C. Effect of environmental tobacco smoke on LDL accumulation in the artery wall. Circulation. 1996 Nov 1;94(9):2248–2253. doi: 10.1161/01.cir.94.9.2248. [DOI] [PubMed] [Google Scholar]
  35. Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986 Feb 20;314(8):488–500. doi: 10.1056/NEJM198602203140806. [DOI] [PubMed] [Google Scholar]
  36. Schmid P., Karanikas G., Kritz H., Pirich C., Stamatopoulos Y., Peskar B. A., Sinzinger H. Passive smoking and platelet thromboxane. Thromb Res. 1996 Feb 15;81(4):451–460. doi: 10.1016/0049-3848(96)00017-5. [DOI] [PubMed] [Google Scholar]
  37. Schmidt K. G., Rasmussen J. W. Acute platelet activation induced by smoking. In vivo and ex vivo studies in humans. Thromb Haemost. 1984 Apr 30;51(2):279–282. [PubMed] [Google Scholar]
  38. Sinzinger H., Kefalides A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet. 1982 Aug 14;2(8294):392–393. doi: 10.1016/s0140-6736(82)90588-8. [DOI] [PubMed] [Google Scholar]
  39. Steenland K. Passive smoking and the risk of heart disease. JAMA. 1992 Jan 1;267(1):94–99. [PubMed] [Google Scholar]
  40. Steenland K., Thun M., Lally C., Heath C., Jr Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation. 1996 Aug 15;94(4):622–628. doi: 10.1161/01.cir.94.4.622. [DOI] [PubMed] [Google Scholar]
  41. Sterling T. D., Rosenbaum W. L., Weinkam J. J. Risk attribution and tobacco-related deaths. Am J Epidemiol. 1993 Jul 15;138(2):128–139. doi: 10.1093/oxfordjournals.aje.a116835. [DOI] [PubMed] [Google Scholar]
  42. Sun Y. P., Zhu B. Q., Sievers R. E., Glantz S. A., Parmley W. W. Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation. 1994 May;89(5):2260–2265. doi: 10.1161/01.cir.89.5.2260. [DOI] [PubMed] [Google Scholar]
  43. Valkonen M., Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation. 1998 May 26;97(20):2012–2016. doi: 10.1161/01.cir.97.20.2012. [DOI] [PubMed] [Google Scholar]
  44. Wagenknecht L. E., Burke G. L., Perkins L. L., Haley N. J., Friedman G. D. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health. 1992 Jan;82(1):33–36. doi: 10.2105/ajph.82.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wells A. J. Heart disease from passive smoking in the workplace. J Am Coll Cardiol. 1998 Jan;31(1):1–9. doi: 10.1016/s0735-1097(97)00432-4. [DOI] [PubMed] [Google Scholar]
  46. Wilson P. W. Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens. 1994 Jul;7(7 Pt 2):7S–12S. doi: 10.1093/ajh/7.7.7s. [DOI] [PubMed] [Google Scholar]
  47. Woo K. S., Robinson J. T., Chook P., Adams M. R., Yip G., Mai Z. J., Lam C. W., Sorensen K. E., Deanfield J. E., Celermajer D. S. Differences in the effect of cigarette smoking on endothelial function in chinese and white adults. Ann Intern Med. 1997 Sep 1;127(5):372–375. doi: 10.7326/0003-4819-127-5-199709010-00006. [DOI] [PubMed] [Google Scholar]
  48. Zhu B. Q., Sun Y. P., Sievers R. E., Glantz S. A., Parmley W. W., Wolfe C. L. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation. 1994 Mar;89(3):1282–1290. doi: 10.1161/01.cir.89.3.1282. [DOI] [PubMed] [Google Scholar]
  49. Zhu B. Q., Sun Y. P., Sievers R. E., Isenberg W. M., Glantz S. A., Parmley W. W. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993 Jan;21(1):225–232. doi: 10.1016/0735-1097(93)90741-i. [DOI] [PubMed] [Google Scholar]
  50. Zhu B. Q., Sun Y. P., Sievers R. E., Isenberg W. M., Glantz S. A., Parmley W. W. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993 Jan;21(1):225–232. doi: 10.1016/0735-1097(93)90741-i. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES